Search

GlaxoSmithKline PLC

Cerrado

Sector Salud

1,340.5 2.33

Resumen

Variación precio

24h

Actual

Mínimo

1340

Máximo

1342.5

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+23.9 upside

Dividendos

By Dow Jones

Próximas Ganancias

5 feb 2025

Fecha Próximo Dividendo

9 ene 2025

Próxima Fecha de Ex Dividendo

20 feb 2025

Noticias sobre sentimiento de mercado

By Acuity

45%

55%

147 / 392 Clasificación en Healthcare

GlaxoSmithKline PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

15 nov 2024, 10:28 UTC

Principales Movimientos del Mercado

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

30 oct 2024, 11:44 UTC

Ganancias

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness -- Update

30 oct 2024, 07:50 UTC

Ganancias

GSK Profit Rises on HIV, Cancer Treatments But Sales Slip on Weak U.S. Vaccine Demand

29 oct 2024, 13:39 UTC

Adquisiciones, fusiones, absorciones

GSK Buys Lupus Treatment For Up To $850 Million From Chimagen Biosciences

15 nov 2024, 13:08 UTC

Principales Noticias

Trump's RFK Pick Weighs on Vaccine Makers -- WSJ

15 nov 2024, 10:34 UTC

Charlas de Mercado

Vaccine Sector Sell-Off Looks Overdone -- Market Talk

15 nov 2024, 10:29 UTC

Acciones populares

Stocks to Watch Friday: Tesla, Domino's, Palantir, Ulta -- WSJ

7 nov 2024, 11:53 UTC

Principales Noticias
Ganancias

Moderna Earnings Beat Estimates. But Its Future Still Looks Uncertain. -- Barrons.com

7 nov 2024, 11:31 UTC

Ganancias

Moderna Earnings Beat Estimates. But Its Future Still Looks Uncertain. -- Barrons.com

31 oct 2024, 19:48 UTC

Principales Noticias

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses -- Update

30 oct 2024, 15:04 UTC

Charlas de Mercado
Ganancias

GSK's 3Q Results Are a Mixed Bag -- Market Talk

30 oct 2024, 08:22 UTC

Charlas de Mercado
Ganancias

GSK's Vaccine Weakness Is a Major Concern -- Market Talk

30 oct 2024, 07:18 UTC

Ganancias

GSK Reiterates Guidance As HIV And Cancer Drug Demand Offset Vaccine Weakness -- MarketWatch

30 oct 2024, 07:04 UTC

Ganancias

GSK PLC Expects to deliver Around Middle of Existing Annual Guidance Ranges

30 oct 2024, 07:03 UTC

Ganancias

GSK PLC 3Q EPS 1.4p

30 oct 2024, 07:02 UTC

Ganancias

GSK PLC Had Seen 2024 Sales Growth of 7% to 9%

30 oct 2024, 07:02 UTC

Ganancias

GSK PLC Issues Dividend of 15p

30 oct 2024, 07:01 UTC

Ganancias

GSK PLC Had Seen 2024 Core Earnings Per Share Growth of 10% to 12%

30 oct 2024, 07:01 UTC

Ganancias

GSK PLC Had Seen 2024 Core Operating Pft Growth Between 11% and 13%

30 oct 2024, 07:01 UTC

Ganancias

GSK PLC Backs 2024 View

30 oct 2024, 07:00 UTC

Ganancias

Analysts Saw GSK PLC 3Q Net Pft GBP1.78B

30 oct 2024, 07:00 UTC

Ganancias

Analysts Saw GSK PLC 3Q Turnover GBP8.00B

30 oct 2024, 07:00 UTC

Ganancias

GSK PLC 3Q Loss/Shr 1.4p

30 oct 2024, 07:00 UTC

Ganancias

GSK PLC 3Q Turnover GBP8.01B

30 oct 2024, 07:00 UTC

Ganancias

GSK PLC 3Q Adj EPS 49.7p

30 oct 2024, 07:00 UTC

Ganancias

GSK PLC 3Q Pre-items, Pretax Pft GBP2.65B

30 oct 2024, 07:00 UTC

Ganancias

GSK PLC 3Q Pretax Pft GBP64M

30 oct 2024, 07:00 UTC

Ganancias

GSK PLC 3Q Oper Pft GBP189M

30 oct 2024, 07:00 UTC

Ganancias

GSK PLC 3Q Net Loss GBP58M

29 oct 2024, 13:24 UTC

Adquisiciones, fusiones, absorciones

GSK Buys Lupus Treatment For Up To $850 Mln From Chimagen Biosciences

GlaxoSmithKline PLC Esperado

Precio Objetivo

By TipRanks

23.9% repunte

Estimación a 12 meses

Media 1,662.73 GBX  23.9%

Máximo 2,610 GBX

Mínimo 1,350 GBX

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para GlaxoSmithKline PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

13 ratings

4

Comprar

7

Mantener

2

Vender

Sentimiento

By Acuity

147 / 392 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

$